Digipath Inc/ US2538252022 /
5/24/2024 9:53:12 PM | Chg. -0.0033 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0260USD | -11.26% | 4,600 Turnover: 109.6250 |
-Bid Size: - | -Ask Size: - | 0.0260 | 0.0162 |
GlobeNewswire
8/29/2023
Digipath Announces Record Earnings of $292,533 for Recent Quarter Ended June 30
GlobeNewswire
3/1/2022
Digipath Enters Into Validation Agreement with CASPR Technologies to Determine Efficacy for New Anti...
GlobeNewswire
2/9/2022
Digipath Obtains Coveted Compliance Testing License for California Laboratory
GlobeNewswire
12/7/2021
Digipath Takes Over Management & Signs Letter of Intent to Acquire Majority Control of Steep Hill’s ...
GlobeNewswire
12/6/2021
Digipath, Inc. to Present at the Emerging Growth Conference on Wednesday, December 8th at 12n EST/ 9...
GlobeNewswire
6/1/2021
Digipath Launches Multi-State Operator (MSO) Strategy with Plans for Opening California Testing Lab
GlobeNewswire
11/10/2020
Taat Inducts Dr. Cindy Orser, Life Sciences Scholar and Executive Biochemist for Projects Funded by ...
GlobeNewswire
5/18/2020
Digipath Announces Results for Second Fiscal Quarter 2020, Revenues Grow 16% and 21% on a Year to Da...
GlobeNewswire
3/24/2020
Digipath Obtains Health Canada R&D License for Cannabis Strain Development and Sales
GlobeNewswire
2/18/2020
Digipath Announces Results for the Fiscal First Quarter 2020, Revenues Grow 26%